Abstract
Within the past 15 years a new family of peptides has been identified, known as trefoil factor family (TFF) domain peptides; they are associated with mucin-secreting epithelial cells and synthesised predominantly in the gastrointestinal tract. They share a highly conserved physical structure, and their role in mucosal defence and healing is becoming increasingly clear; more recently a tumour suppressor function has been postulated. Outside the gastrointestinal tract, members of this group of peptides have also been identified in the normal hypothalamus and pituitary, and in normal breast tissue where it is responsive to oestrogen stimulation. Evidence of peptide expression has been found in a range of urological, gynaecological, gastrointestinal, pulmonary and breast carcinomas, and in the last two it appears to carry prognostic significance. The present review aims to summarise the rapidly expanding data on the role of these peptides in epithelial inflammation, repair and neoplasia.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 21 July 1997 / Accepted: 21 July 1997
Rights and permissions
About this article
Cite this article
Williams, G., Wright, N. Trefoil factor family domain peptides. Virchows Archiv 431, 299–304 (1997). https://doi.org/10.1007/s004280050102
Issue Date:
DOI: https://doi.org/10.1007/s004280050102